Chemotherapy-treated breast cancer patients carrying APOE-4 allele E4, a well-known risk factor for Alzheimer's disease (Ahles, 2012), have a higher risk of cognitive dysfunction during the course of cancer treatment (Mandelblatt et al., 2013). Here, APOE is linked to cancer.